{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T05:21:29Z","timestamp":1702704089193},"reference-count":25,"publisher":"Japan Neurosurgical Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2020]]},"DOI":"10.2176\/nmc.oa.2019-0225","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T22:04:55Z","timestamp":1580421895000},"page":"156-163","source":"Crossref","is-referenced-by-count":4,"title":["Changes in Real-world Practice Patterns of Antiepileptic Drugs for Status Epilepticus: A Nationwide Observational Study in Japan"],"prefix":"10.2176","volume":"60","author":[{"given":"Kensuke","family":"NAKAMURA","sequence":"first","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Hitachi General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"OHBE","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"MATSUI","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"TAKAHASHI","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Hitachi General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiki","family":"MARUSHIMA","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Tsukuba University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"INOUE","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Tsukuba University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohide","family":"FUSHIMI","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"YASUNAGA","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Chapman MG, Smith M, Hirsch NP: Status epilepticus. <i>Anaesthesia<\/i> 56: 648\u2013659, 2001","DOI":"10.1046\/j.1365-2044.2001.02115.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Trinka E, Cock H, Hesdorffer D, et al.: A definition and classification of status epilepticus\u2014Report of the ILAE Task Force on Classification of Status Epilepticus. <i>Epilepsia<\/i> 56: 1515\u20131523, 2015","DOI":"10.1111\/epi.13121"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kapur J, Macdonald RL: Rapid seizure-induced reduction of benzodiazepine and Zn<sup>2+<\/sup> sensitivity of hippocampal dentate granule cell GABAA receptors. <i>J Neurosci<\/i> 17: 7532\u20137540, 1997","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Treiman DM, Meyers PD, Walton NY, et al.: A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. <i>N Engl J Med<\/i> 339: 792\u2013798, 1998","DOI":"10.1056\/NEJM199809173391202"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Brophy GM, Bell R, Claassen J, et al.: Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17: 3\u201323, 2012","DOI":"10.1007\/s12028-012-9695-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Chang CW, Bleck TP: Status epilepticus. <i>Neurol Clin<\/i> 13: 529\u2013548, 1995","DOI":"10.1016\/S0733-8619(18)30033-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Coplin WM, Rhoney DH, Rebuck JA, Clements EA, Cochran MS, O\u2019Neil BJ: Randomized evaluation of adverse events and length-of-stay with routine emergency department use of phenytoin or fosphenytoin. <i>Neurol Res<\/i> 24: 842\u2013848, 2002","DOI":"10.1179\/016164102101200834"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Swadron SP, Rudis MI, Azimian K, Beringer P, Fort D, Orlinsky M: A comparison of phenytoin-loading techniques in the emergency department. <i>Acad Emerg Med<\/i> 11: 244\u2013252, 2004","DOI":"10.1197\/j.aem.2003.10.022"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Meehan AL, Yang X, McAdams BD, Yuan L, Rothman SM: A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam. <i>J Neurophysiol<\/i> 106: 1227\u20131239, 2011","DOI":"10.1152\/jn.00279.2011"},{"key":"10","unstructured":"10) Mundlamuri RC, Sinha S, Subbakrishna DK, et al.: Management of generalised convulsive status epilepticus (SE): a prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam\u2014Pilot study. <i>Epilepsy Res<\/i> 114: 52\u201358, 2015"},{"key":"11","unstructured":"11) Gujjar AR, Nandhagopal R, Jacob PC, et al.: Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: a prospective, randomized study. <i>Seizure<\/i> 49: 8\u201312, 2017"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Chakravarthi S, Goyal MK, Modi M, Bhalla A, Singh P: Levetiracetam versus phenytoin in management of status epilepticus. <i>J Clin Neurosci<\/i> 22: 959\u2013963, 2015","DOI":"10.1016\/j.jocn.2014.12.013"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nakamura K, Inokuchi R, Daidoji H, et al.: Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus. <i>Medicine<\/i> (<i>Baltimore<\/i>) 96: e7206, 2017","DOI":"10.1097\/MD.0000000000007206"},{"key":"14","unstructured":"14) Glauser T, Shinnar S, Gloss D, et al.: Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. <i>Epilepsy Curr<\/i> 16: 48\u201361, 2016"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Shih JJ, Whitlock JB, Chimato N, Vargas E, Karceski SC, Frank RD: Epilepsy treatment in adults and adolescents: expert opinion, 2016. <i>Epilepsy Behav<\/i> 69: 186\u2013222, 2017","DOI":"10.1016\/j.yebeh.2016.11.018"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Meierkord H, Boon P, Engelsen B, et al.: EFNS guideline on the management of status epilepticus in adults. <i>Eur J Neurol<\/i> 17: 348\u2013355, 2010","DOI":"10.1111\/j.1468-1331.2009.02917.x"},{"key":"17","unstructured":"17) Matsuda S: Development of case mix based evaluation system in Japan. <i>Jpn Hosp<\/i> 35\u201344, 2016"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H: Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. <i>J Epidemiol<\/i> 27: 476\u2013482, 2017","DOI":"10.1016\/j.je.2016.09.009"},{"key":"19","unstructured":"19) Jette N, Beghi E, Hesdorffer D, et al.: ICD coding for epilepsy: past, present, and future\u2014a report by the International League Against Epilepsy Task Force on ICD codes in epilepsy. <i>Epilepsia<\/i> 56: 348\u2013355, 2015"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Shigematsu K, Nakano H, Watanabe Y: The eye response test alone is sufficient to predict stroke outcome\u2014reintroduction of Japan Coma Scale: a cohort study. <i>BMJ Open<\/i> 3: pii: e002736, 2013","DOI":"10.1136\/bmjopen-2013-002736"},{"key":"21","unstructured":"21) World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization."},{"key":"22","unstructured":"22) Royston P: PTREND: Stata module for trend analysis for proportions. Statistical Software Components S426101, 2014."},{"key":"23","unstructured":"23) Coveney J: JONTER: Stata module to perform Jonckheere\u2013Terpstra test. Statistical Software Components S423601, 2002."},{"key":"24","unstructured":"24) Ramael S, Daoust A, Otoul C, et al.: Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. <i>Epilepsia<\/i> 47: 1128\u20131135, 2006"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Faught E, Helmers S, Thurman D, Kim H, Kalilani L: Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: a US database analysis. <i>Epilepsy Behav<\/i> 85: 37\u201344, 2018","DOI":"10.1016\/j.yebeh.2018.05.019"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/60\/3\/60_oa.2019-0225\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:28:28Z","timestamp":1614212908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/60\/3\/60_oa.2019-0225\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2176\/nmc.oa.2019-0225","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}